INTERNATIONAL PATENT: DANA-FARBER CANCER INSTITUTE, INC., THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK FILES APPLICATION FOR "SREB/HMGCR INHIBITION IN CANCER WITH CHROMOSOME 3Q GAIN"

GENEVA, Dec. 17 -- DANA-FARBER CANCER INSTITUTE, INC. (450 Brookline AvenueBoston, Massachusetts 02215), THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (535 West 115th StreetNew York, New York 10027) filed a patent application (PCT/US2025/032434) for "SREB/HMGCR INHIBITION IN CANCER WITH CHROMOSOME 3Q GAIN" on Jun 05, 2025. With publication no. WO/2025/255338, the details related to the patent application was published on Dec 11, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): MEYERSON, Matthew (c/o Dana-Farber Cancer Insitute, Inc.450 Brookline AvenueBoston, Massachusetts 02215...